The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35peptide‐induced toxicity in mice involve an interaction with the σ1receptor
Open accessAbstract
Background and purpose: The acetylcholinesterase inhibitor, donepezil, is also a high affinity σ 1 receptor agonist. We examined the involvement of σ 1 receptors in its anti‐amnesic and neuroprotective properties against amyloid β 25‐35 peptide‐induced toxicity in mice. Experimental approach: Mice were given an intracerebroventricular (i.c.v.) injection of Aβ 25‐35 peptide (9 nmol) 7‐9 days before being tested for spontaneous alternation and passive avoidance. Hippocampal lipid peroxidation was measured 7 days after Aβ 25‐35 injection to evaluate oxidative stress. Donepezil, the σ 1 agonist PRE‐084 or the cholinesterase (ChE) inhibitors tacrine, rivastigmine and galantamine were administered either 20 min before behavioural sessions to check their anti‐amnesic effects, or 20 min before Aβ 25‐35 injection, or 24 h after Aβ 25‐35 injection and then once daily before behavioural sessions, to check their pre‐ and post‐i.c.v. neuroprotective activity, respectively. Key results: All the drugs tested were anti‐amnesic, but only the effects of PRE‐084 and donepezil were prevented by the σ 1 antagonist BD1047. Only PRE‐084 and donepezil showed neuroprotection when administered pre i.c.v.; they blocked lipid peroxidation and learning deficits, effects inhibited by BD1047. Post i.c.v., PRE‐084 and donepezil showed complete neuroprotection whereas the other ChE inhibitors showed partial effects. BD1047 blocked these effects of PRE‐084, attenuated those of donepezil, but did not affect the partial effects of the other ChE inhibitors. Conclusions and implications.: The potent anti‐amnesic and neuroprotective effects of donepezil against Aβ 25‐35‐induced toxicity involve both its cholinergic and σ 1 agonistic properties. This dual action may explain its sustained activity compared to other ChE inhibitors. British Journal of Pharmacology(2006)149, 998–1012. doi:10.1038/sj.bjp.0706927
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O., Herman, M. M., Pramoonjago, P., Spaulding, N. K., & Savory, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.002 · Cited by 31
RetractedFunctional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · cited 1×
“The truncated Ab25–35 fragment includes extracellular and transmembrane residues that have been reported to represent an active region of Ab (Yankner et al., 1990).”
BackgroundMattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Vitamin E protects nerve cells from amyloid βprotein toxicity
Behl, C., Davis, J., Cole, G. M., & Schubert, D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90837-b · Cited by 581
Hermes-Lima, M., Willmore, W. G., & Storey, K. B. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00020-x · Cited by 523
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., & Yankner, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7247 · Cited by 522
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 521
Self-citationβ-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Mammalian stress response: induction of the glucose-regulated protein family
Lee, A. S. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90042-b · Cited by 442
Yu, Z., Luo, H., Fu, W., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7002 · Cited by 438
A potential role for apoptosis in neurodegeneration and Alzheimer's disease
Cotman, C. W., & Anderson, A. J. (1995) · Molecular Neurobiology · doi:10.1007/bf02740836 · Cited by 378
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35
Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F., & Angeretti, N. (1993) · NeuroReport · doi:10.1097/00001756-199305000-00015 · Cited by 341
Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity
Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420205 · Cited by 321
HAYASHI, T., Maurice, T., & Su, T. (2000) · PubMed · Cited by 296
Self-citationMaurice, T., Su, T.-P., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291
Self-citationβ-Amyloid protein-induced Alzheimer's disease animal model
Nitta, A., Itoh, A., Hasegawa, T., & Nabeshima, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90239-9 · Cited by 266
Hayashi, T., & Su, T.-P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051284 · Cited by 262
In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment
Kowall, N. W., McKee, A. C., Yankner, B. A., & Beal, M. F. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90053-z · Cited by 224
Amyloid β peptide induces necrosis rather than apoptosis
Behl, C., Davis, J. B., Klier, F. G., & Schubert, D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91659-4 · Cited by 220
Maurice, T., Hiramatsu, M., Itoh, J., Kameyama, T., Hasegawa, T., & Nabeshima, T. (1994) · Brain Research · doi:10.1016/0006-8993(94)91397-8 · Cited by 214
Self-citationNeuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
Maurice, T., & Lockhart, B. P. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00160-1 · Cited by 211
Self-citationNeuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8
Ivins, K. J., Thornton, P. L., Rohn, T. T., & Cotman, C. W. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0268 · Cited by 188
Jhoo, J. H., Kim, H.-C., Nabeshima, T., Yamada, K., Shin, E.-J., Jhoo, W.-K., Kim, W., Kang, K.-S., Jo, S. A., & Woo, J. I. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.012 · Cited by 183
Maurice, T., Phan, V.-L., Urani, A., Kamei, H., Noda, Y., & Nabeshima, T. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.125 · Cited by 178
Self-citationMorin-Surun, M. P., Collin, T., Denavit-Saubié, M., Baulieu, E.-E., & Monnet, F. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8196 · Cited by 170
Flood, J. F., Morley, J. E., & Roberts, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3363 · Cited by 164
Ogura, H., Kosasa, T., Kuriya, Y., & Yamanishi, Y. (2000) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2000.22.8.701373 · Cited by 162
Arias, E., Alés, E., Gabilan, N. H., Cano‐Abad, M. F., Villarroya, M., Garcı́a, A. G., & López, M. G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00317-4 · Cited by 151
In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat
Delobette, S., Privat, A., & Maurice, T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00922-3 · Cited by 143
Self-citationNitta, A., Fukuta, T., Hasegawa, T., & Nabeshima, T. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.73.51 · Cited by 142
Emre, M., Geula, C., Ransil, B., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90055-3 · Cited by 139
Dysfunction of Cholinergic and Dopaminergic Neuronal Systems in β‐Amyloid Protein‐Infused Rats
Itoh, A., Nitta, A., Nadai, M., Kyoko, N., Hirose, M., Hasegawa, T., & NABESHIMA, T. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031113.x · Cited by 134
Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus
Stepanichev, M. Y., Zdobnova, I. M., Zarubenko, I. I., Moiseeva, Y. V., Лазарева, Н. А., Onufriev, M. V., & Gulyaeva, N. V. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2003.11.003 · Cited by 132
β‐Amyloid Neurotoxicity In Vitro: Evidence of Oxidative Stress but Not Protection by Antioxidants
Pike, C. J., Ramezan‐Arab, N., & Cotman, C. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041601.x · Cited by 130
Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
Itoh, A., Akaike, T., Sokabe, M., Nitta, A., Iida, R., Olariu, A., Yamada, K., & Nabeshima, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00601-9 · Cited by 129
Stepanichev, M. Y., Moiseeva, Y. V., Лазарева, Н. А., Onufriev, M. V., & Gulyaeva, N. V. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00118-7 · Cited by 125
Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity
Kihara, T., Sawada, H., Nakamizo, T., Kanki, R., Yamashita, H., Maelicke, A., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.132 · Cited by 124
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity
Marrazzo, A., Caraci, F., Salinaro, E. T., Su, T., Copani, A., & Ronsisvalle, G. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00018 · Cited by 120
Su, T., Wu, X. Z., Cone, E. J., Shukla, K. L., Gund, T., Dodge, A. L., & Parish, D. W. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20283-x · Cited by 110
Hayashi, T., & Su, T. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.009 · Cited by 100
Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25-35) in rat PC12 cells
Svensson, A., & Nordberg, A. K. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00050 · Cited by 100
Kato, K., Hayako, H., Ishihara, Y., Marui, S., Iwane, M., & Miyamoto, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00943-4 · Cited by 95
Olariu, A., Tran, M. H., Yamada, K., Mizuno, M., Hefco, V., & Nabeshima, T. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170025 · Cited by 92
Immunocytochemical evidence that amyloid β (1–42) impairs endogenous antioxidant systems in vivo
Kim, H., Yamada, K., Nitta, A., Olariu, A., Tran, M. H., Mizuno, M., Nakajima, A., Nagai, T., Kamei, H., Jhoo, W., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00993-4 · Cited by 89
Nicotine modulates the neurotoxic effect of β-amyloid protein(25–35) in hippocampal cultures
Zamani, R., Allen, Y. S., Owen, G. P., & Gray, J. A. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00027 · Cited by 85
Takebayashi, M., Hayashi, T., & Su, T. (2004) · Synapse · doi:10.1002/syn.20041 · Cited by 84
Maurice, T., Meunier, J., Feng, B., Ieni, J. R., & Monaghan, D. T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097394 · Cited by 81
Self-citationTran, M. H., Yamada, K., Nakajima, A., Mizuno, M., He, J., Kamei, H., & Nabeshima, T. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001240 · Cited by 80
Cho, J., Kim, H., Kim, D., Yan, J.-J., Suh, H., & Song, D. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.022 · Cited by 75
Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons
Kimura, M., Akasofu, S., Ogura, H., & Sawada, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.014 · Cited by 75
Yamada, K., Takayanagi, M., Kamei, H., Nagai, T., Dohniwa, M., Kobayashi, K., Yoshida, S., Oh-hara, T., Takauma, K., & Nabeshima, T. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.036 · Cited by 75
Mamiya, T., Asanuma, T., Kise, M., Ito, Y., Mizukuchi, A., Aoto, H., & Ukai, M. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1041 · Cited by 73
Cullen, W. K., Wu, J., Anwyl, R., & Rowan, M. J. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00018 · Cited by 65
Effect of beta amyloid peptides on neurons in hippocampal slice cultures
Malouf, A. T. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90054-2 · Cited by 63
Giovannelli, L., Scali, C., Faussone‐Pellegrini, M. S., Pepeu, G., & Casamenti, F. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00169-9 · Cited by 61
Activation of σ1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures
Nakazawa, M., Matsuno, K., & Mita, S. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00105-8 · Cited by 55
Stepanichev, M. Y., Zdobnova, I. M., Zarubenko, I. I., Лазарева, Н. А., & Gulyaeva, N. V. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0167-1 · Cited by 51
Trubetskaya, V. V., Stepanichev, M. Y., Onufriev, M. V., Лазарева, Н. А., Markevich, V. A., & Gulyaeva, N. V. (2003) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1021761310435 · Cited by 44
Stepanichev, M. Y., Moiseeva, Y. V., Лазарева, Н. А., & Gulyaeva, N. V. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0086-1 · Cited by 38
Café, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G., & Marzatico, F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12250-8 · Cited by 37
Meunier, J., Ieni, J. R., & Maurice, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101527 · Cited by 35
Self-citation
Cited by
Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.
Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108352 · Cited by 1,147
The pharmacology of sigma-1 receptors.
Maurice, T., & Su, T.-P. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.001 · Cited by 654
Self-citationNew insights into brain BDNF function in normal aging and Alzheimer disease
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.007 · Cited by 571
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Su, T.-P., Hayashi, T., Maurice, T., Buch, S., & Ruoho, A. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.007 · Cited by 466
Self-citationThe Infectious Etiology of Alzheimer’s Disease
Sochocka, M., Zwolińska, K., & Leszek, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170313122937 · Cited by 399
Metadata
- Authors
- Meunier, J., Ieni, J., & Maurice, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-12
- Volume
- 149
- Issue
- 8
- Pages
- 998-1012
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1500642137
- Cited by
- 288
- References
- 70
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.